According to a report,“Arrhythmia Monitoring Devices Market Size, Share & Trends Analysis Report By Type (ECG, Implantable, Holter, Mobile Cardiac Telemetry), By Application, By End Use, And Segment Forecasts, 2018 – 2025”, published by Grand View Research, Inc., The global arrhythmia monitoring devices market size is expected to reach USD 8.41 billion in 2025 with a CAGR of 6.8% during the forecast period. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.
Key Takeaways from the report:
-
The arrhythmia monitoring devices market is highly competitive and is rapidly evolving with numerous potential market players
-
Holter monitors dominated the market in terms of revenue in 2017. On the other hand, mobile cardiac telemetry is expected to witness the fastest growth rate during the forecast period
-
Atrial fibrillation dominated the market in terms of revenue in 2017. The growth in the number of untreated cases of arrhythmias are leading to increasing need for advanced cardiac monitoring devices
-
Heightened adoption of sophisticated technologies has led to the expansion of the market. Kardia Mobile by AliveCor captures ECG in 30 seconds projecting the heart rhythm for conditions such as atrial fibrillation
-
The hospitals and clinics segment held the largest share in the market in 2017. On the other hand, diagnostic centers are likely to experience the fastest growth over the forecast period
-
North America commanded the leading share in the market in 2017 due to faster regulatory approvals for innovative devices and procedures
-
AliveCor, Inc.; Applied Cardiac Systems; BioTelemetry, Inc.; BIOTRONIK; Fukuda Denshi Co., Ltd.; GE Healthcare; iRhythm; Medi-Lynx; St. Jude Medical (Abbott); Medtronic; Nihon Kohden Corporation; Nuubo; and Spacelabs Healthcare are some of the key players operating in this market.
Browse More Reports in Medical Devices:
• Intraocular Lens (IOL) Market: Factors such as rise in prevalence of cataract, increasing aging population with high risk of developing ocular conditions, and government initiatives focused on reducing instances of preventable blindness are expected to drive the intraocular lenses (IOLs) market.
• Radiation Detection, Monitoring And Safety Market: Rising adoption of nuclear medicine and radiation therapy as a consequence of the increasing global incidences of cancer are expected to drive the market growth over the forecast period.
Big pharma and medical device companies are heavily investing in R&D to perform a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for the first non-invasive cardiac mapping system, CardioInsight. It includes wearable 252-electrode sensor vest that creates 3D electroanatomic maps of heart by combining data from a cardiac computed tomography scan with ECG signals collected from the chest region.
In addition to these technologies, emergence and advancements in mobile cardiac telemetry are leading to further progress of the overall market. In October 2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible implantable cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced its FDA approval for Resonate, a line of cardiac resynchronization therapy defibrillator and cardioverter defibrillator systems for the cardiac management.
Grand View Research has segmented the global arrhythmia monitoring devices market based on type, application, end use, and region:
Arrhythmia Monitoring Devices Type Outlook (Revenue, USD Million, 2014 – 2025)
-
ECG Monitors
-
Implantable Monitors
-
Holter Monitors
-
Mobile Cardiac Telemetry
Arrhythmia Monitoring Devices Application Outlook (Revenue, USD Million, 2014 – 2025)
-
Bradycardia
-
Tachycardia
-
Atrial Fibrillation
-
Ventricular Fibrillation
-
Premature Contraction
-
Others
Arrhythmia Monitoring Devices End Use Outlook (Revenue, USD Million, 2014 – 2025)
-
Hospitals & Clinics
-
Diagnostic Centers
-
Others
Arrhythmia Monitoring Devices Regional Outlook (Revenue, USD Million, 2014 – 2025)
-
North America
-
U.S.
-
Canada
-
Europe
-
U.K.
-
Germany
-
France
-
Italy
-
Spain
-
Asia Pacific
-
Japan
-
China
-
India
-
Latin America
-
Brazil
-
Mexico
-
Middle East & Africa
-
South Africa
Explore arrhythmia monitoring devices market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/arrhythmia-monitoring-devices-market